[Second tumors in patients treated for Hodgkin's disease].
España
P
P
Bonilla
F
F
Yebra
M
M
Diego
J
J
Alvarez de Mon
M
M
Marazuela
M
M
Durántez
A
A
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000209:etiology*; D003131:Combined Modality Therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007938:Leukemia / Q000209:etiology*; D008175:Lung Neoplasms / Q000209:etiology*; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology*; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone
Segundos tumores en enfermos tratados por enfermedad de Hodgkin.